Abordagem Diagnstica e Teraputica de Varizes Gastroesofg.pdf

32 – Garcia-Tsao G, D’Amico G, Abraldes JG, Schepis F, Merli M, Kim WR, et al. Predictive
models in portal hypertension. In: de Franchis R. Portal Hypertension IV. Proceedings of the
Fourth Baveno International Consensus
Workshop on Methodology of Diagnosis and Treatment. Oxford, UK: Blackwell, 2006:47-100.
33 – de Franchis R. Updating consensus in portal hypertension: Report of the Baveno III
consensus workshop on definitions, methodology and therapeutic strategies in portal
hypertension. J Hepatol 2000;33:846-852.
34 – Eisen GM, Eliakim R, Zaman A, Schwartz J, Faigel D, Rondonotti E, et al. The accuracy of
PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of
esophageal varices: a prospective three-center pilot study. Endoscopy 2006;38:31-35.
35 –Lapalus MG, Dumortier J, Fumex F, Roman S, Lot M, Prost B, et al. Esophageal capsule
endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a
prospective comparative study of performance
and tolerance. Endoscopy 2006;38:36-41.
36 – Blei AT, Garcia-Tsao G, Groszmann RJ, Kahrilas P, Ganger D, Fung HL. Hemodynamic
evaluation of isosorbide dinitrate in alcoholic cirrhosis: Pharmacokinetic-hemodynamic
interactions. Gastroenterology 1987;93:576-583.
37 – D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an
evidence-based approach. Semin Liver Dis 1999;19: 475-505.
38 – Cales P, Oberti F, Payen JL, Naveau S, Guyader D, Blanc P, et al. Lack of effect of
propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a
randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J
Gastroenterol Hepatol 1999;11:741-745.
39 – Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, et al. A placebocontrolled
clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in
cirrhosis. Gastroenterology 2004;127:476-484.
40 – de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV
Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J
Hepatol 2005;43:167-176.
41 - Garcia-Tsao, G, Sanyal, AJ, Grace, ND, et al. Prevention and management of
gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46:922-938
42 – Chen W, Nikolova D, Frederiksen SL, Gluud C. Beta-blockers reduce mortality in cirrhotic
patients with oesophageal varices who have never bled (Cochrane review). J Hepatol
2004;40(Suppl 1):67 (abstract).
43 – Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ. Primary prophylaxis of
variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997;112:473-
482.
44 – Wiest R, Groszmann RJ. Nitric oxide and portal hypertension: its role in the regulation of
intrahepatic and splanchnic vascular resistance. Semin Liver Dis 2000;19:411-426.
45 - Sanyal, AJ, Shiffman, ML. The pharmacologic treatment of portal hypertension. Annu Rev
Gastrointest Pharmacol 1996; 242.
28